pharmaceuticals

Private equity-backed Headlands Research heralded its COVID vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.

The proposed case accuses Roche Laboratories and Genentech of intentionally misleading the federal government about mefloquine. The judge said the lawsuit should not be filed in California.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

The Biden administration denies the state's allegations that it is "protecting the interests of pharmaceutical companies" or that it has not properly complied with a public records request.

While sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.

People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.

Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.

President Biden is urging swift House passage, and the House seems on track to provide final congressional approval when it returns briefly from summer recess on Friday.

West Virginia Sen. Joe Manchin reached an agreement with Senate Majority Leader Chuck Schumer that had eluded them for months on health care costs, energy and climate issues.

The deal in principle would rank among the larger ones in a yearslong trend of companies settling complicated lawsuits over the toll from an addiction and overdose epidemic. That includes a $117 million settlement with Florida announced in March.